Risk | Very High |
---|---|
Min SIP Amount | ₹100 |
Expense Ratio | 1.40% |
NAV | ₹42.05 (25 Feb 2021) |
---|---|
Fund Started | 02 Jan 2013 |
Fund Size | ₹1,075 Cr |
Name | Sector | Instrument | % Assets |
---|---|---|---|
Salesforce Com. | Technology | Forgn. Eq | 3.2% |
Coca Cola Co. (US) | FMCG | Forgn. Eq | 3.0% |
Mc DonaldS Corporation (US) | Services | Forgn. Eq | 3.0% |
Biogen Idec Inc. (USA) | Healthcare | Forgn. Eq | 3.0% |
Intel Corporation (USA) | Technology | Forgn. Eq | 3.0% |
Northrop Grumman Co. (US) | Others | Forgn. Eq | 2.9% |
Bank of America | Financial | Forgn. Eq | 2.9% |
Gilead Sciences Inc. (USA) | Healthcare | Forgn. Eq | 2.9% |
Lockheed Martin Corp | Services | Forgn. Eq | 2.9% |
Corteva Inc. | Chemicals | Forgn. Eq | 2.8% |
ICICI Prudential US Bluechip Equity Direct Plan Growth is a Equity Mutual Fund Scheme launched by ICICI Prudential Mutual Fund. This scheme was made available to investors on 02 Jan 2013. Rohan Maru, Priyanka Khandelwal is the Current Fund Manager of ICICI Prudential US Bluechip Equity Direct Plan Growth fund.The fund currently has an Asset Under Management(AUM) of ₹1,075 Cr and the Latest NAV as of 25 Feb 2021 is ₹42.05.
The ICICI Prudential US Bluechip Equity Direct Plan Growth is rated Very High risk. Minimum SIP Investment is set to 100. Minimum Lumpsum Investment is 5000. Exit load of 1% if redeemed within 1 month.
The investment objective of ICICI Prudential US Bluechip Equity Fund is to provide long term capital appreciation to investors by primarily investing in equity and equity related securities of companies listed on recognized stock exchanges in the United States of America. The Scheme shall also invest in ADRs/GDRs issued by Indian and foreign companies.
Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.